The stock of pharma major Dr. Reddy's Laboratories was buzzing on Thursday as market expected the company to receive US drug regulator's approval for blockbuster cancer drug imatinib mesylate.

Double-digit returns in the longer term is what most mutual fund investors desire for. Mutual fund investments are meant for the long-term wealth creation and investors usually invest in the schemes for achieving long-term financial goals.

Sun Pharmaceutical Industries Limited has received approval for CEQUA (cyclosporine ophthalmic solution) 0.09%, from the US Food and Drug Administration (FDA). CEQUA is indicated to increase the tear production in patients that suffer from the condition of Keratoconjunctivitis sicca that is, dry eyes.

Road and infrastructure builder, KNR Construction may sell four of its HAM (Hybrid Annuity Model) projects, reported a leading business daily. The company is said to be in talks with private equity firm Brookfield and Cube Highway for the deal.

Following stocks are close to their 52-week low as at 12.40 p.m. on August 16, 2018.

The markets on August 16, 2018 opened down. BSE Sensex is trading at 37,815.08, down by 36.92 points and the Nifty is trading at 11,422.90, down by 12.20 points. 

During the quarter, the company won new orders amounting to Rs. 2,744.1 crore. The net order book as on June 30 stood at Rs. 24,090.3 crore.

Making a portfolio will help you achieve your financial goals, however, a disciplined approach is needed to make a strong portfolio.

Overall volumes in futures & options currently stand at 75.25 lakh contracts with a turnover of Rs. 7,49,496.29 crore.

Overall volumes in futures & options currently stand at 75.25 lakh contracts with a turnover of Rs. 7,49,496.29 crore.